Study to Test the Efficacy and Safety of Vafidemstat in Adult Borderline Personality Disorder Population

Completed · Phase 2 · Has a placebo group

Conditions studied: Borderline Personality Disorder

In brief

PORTICO is a Phase IIb study to evaluate the efficacy and safety of vafidemstat in an adult borderline personality disorder (BPD) population.

Key facts

Study ID
NCT04932291
Run by
Oryzon Genomics S.A.
People needed
211
Starts
2021-03-26
Expected to finish
2023-11-13
Last updated by the study team
2026-05-05

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.